Loading
PSA screening finds harmless prostate cancers that would never cause trouble. Selecting men by PSA plus a polygenic risk score, then MRI before any biopsy and targeted biopsy only for PI-RADS 4 to 5 lesions, finds the dangerous cancers and skips the rest; GOTEBORG-2 showed MRI-targeted biopsy halves overdiagnosis.
GOTEBORG-2 showed MRI-targeted biopsy halves overdiagnosis; BARCODE1 showed polygenic-score-selected men have high rates of clinically significant cancer. The UK TRANSFORM trial will compare pathways. Propose a national screening design combining PRS/PSA pre-selection, MRI, and targeted biopsy only for PI-RADS 4-5 lesions.
Shares Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction, Polygenic risk score (PRS), Judge a prostate screening programme on metastatic presentation, not on incidence or mortality, The Institute of Cancer Research.
Shares PI-RADS (Prostate Imaging Reporting and Data System), Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment, Overdiagnosis and false alarms, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch.
Shares Polygenic risk score (PRS), PI-RADS (Prostate Imaging Reporting and Data System), Judge a prostate screening programme on metastatic presentation, not on incidence or mortality, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch.
Shares Judge a prostate screening programme on metastatic presentation, not on incidence or mortality, Overdiagnosis and false alarms, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch, Prostate cancer.
Shares PI-RADS (Prostate Imaging Reporting and Data System), Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment, Overdiagnosis and false alarms, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch.
Shares PI-RADS (Prostate Imaging Reporting and Data System), Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch, MRI.
Shares PI-RADS (Prostate Imaging Reporting and Data System), Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch, Prostate cancer.
Shares PI-RADS (Prostate Imaging Reporting and Data System), Publish a per-lesion miss rate for every prostate MRI service before it is allowed to guide focal treatment, Overdiagnosis and false alarms, MRI.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/